Article
APOE4 to APOE2 allelic switching in mice improves Alzheimer's disease-related metabolic signatures, neuropathology and cognition.
Nature neuroscience - 1 Dec 2025
Golden Lesley R, Siano Dahlia S, Stephens Isaiah O, MacLean Steven M, Saito Kai, Nolt Georgia L, Funnell Jessica L, Pallerla Akhil V, Lee Sangderk, Smith Cathryn, Chen Jing, Zhu Haining, Voy Clairity, Whitus Callie M, Hernandez Gabriela, Farmer Brandon C, Pandya Kumar, Cowley Dale O, Macauley Shannon L, Gordon Scott M, Morganti Josh M, Johnson Lance A
Abstract excerpt
Compared to individuals carrying two copies of the ε4 allele of apolipoprotein E (APOE), ε2 homozygotes have an approximate 99% reduction in late-onset Alzheimer's disease (AD) risk. Here we develop a knock-in model that allows for an inducible 'switch' between risk and protective alleles (APOE4s2). Gene expression and proteomic analyses confirm that APOE4s2 mice synthesize E4 at baseline and E2 after tamoxifen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
